Related Experiment Video

Updated: Mar 3, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Chronic Disease Prevalence and Medicare Advantage Market Penetration: Findings From the Medical Expenditure Panel

Steven W Howard1, Stephanie Lazarus Bernell2, Faizan M Casim3

  • 1Health Management and Policy, Saint Louis University, St Louis, MO, USA.

Health Services Research and Managerial Epidemiology
|May 3, 2017
PubMed

Insights

Higher Medicare Advantage (MA) plan enrollment is linked to better cardiometabolic health outcomes for beneficiaries. Increased MA market penetration correlates with a reduced burden of chronic disease, suggesting positive population-level health impacts.

Area of Science:

  • Health Services Research
  • Public Health
  • Health Economics

Background:

  • Medicare Advantage (MA) plans are increasingly popular, with 30% of beneficiaries enrolled by March 2015.
  • Existing research has not investigated the effects of MA market penetration on health outcomes.
  • Understanding these impacts is crucial for evaluating healthcare policy and beneficiary well-being.

Purpose of the Study:

  • To examine the relationship between Medicare Advantage market penetration and the cardiometabolic disease burden of Medicare beneficiaries.
  • To assess how the prevalence of MA plans influences the health status of individuals with chronic conditions.

Main Methods:

  • Utilized 2004-2008 Medical Expenditure Panel Survey (MEPS) Household Component data.
  • Constructed a Chronic Disease Severity Index (CDSI) to measure the portfolio of cardiometabolic diagnoses.
  • Merged MEPS data for 8089 beneficiaries with MA market penetration data from CMS.
  • Employed ordinary least squares regression analysis using SAS 9.3.

Main Results:

  • Each 1% increase in MA market penetration was associated with a >2-point decrease in the CDSI.
  • This indicates a reduced burden of cardiometabolic chronic disease in areas with higher MA penetration.
  • Findings suggest potential positive spill-over effects on the health of the broader beneficiary population.

Conclusions:

  • Higher Medicare Advantage market penetration is associated with improved cardiometabolic health outcomes among Medicare beneficiaries.
  • The study highlights the potential public health benefits of increased MA plan adoption.
  • Further research into spill-over effects is warranted to fully understand MA's population health impact.
Keywords:
MEPSMedicare Advantagecardiometabolic conditionscardiovascular diseasediabetesmarket penetrationspill-over effects

More Related Videos

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.6K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
663
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
984
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.5K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.1K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
55